Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: E9B4K9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 408 | 412 | PF00656 | 0.499 |
CLV_NRD_NRD_1 | 84 | 86 | PF00675 | 0.567 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.510 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.510 |
CLV_PCSK_SKI1_1 | 103 | 107 | PF00082 | 0.524 |
CLV_PCSK_SKI1_1 | 244 | 248 | PF00082 | 0.436 |
CLV_PCSK_SKI1_1 | 260 | 264 | PF00082 | 0.540 |
CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.500 |
CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.416 |
CLV_Separin_Metazoa | 60 | 64 | PF03568 | 0.509 |
DEG_APCC_DBOX_1 | 331 | 339 | PF00400 | 0.474 |
DOC_CDC14_PxL_1 | 245 | 253 | PF14671 | 0.498 |
DOC_USP7_MATH_1 | 116 | 120 | PF00917 | 0.563 |
DOC_USP7_MATH_1 | 185 | 189 | PF00917 | 0.570 |
DOC_USP7_MATH_1 | 213 | 217 | PF00917 | 0.513 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.640 |
DOC_USP7_MATH_1 | 405 | 409 | PF00917 | 0.588 |
DOC_WW_Pin1_4 | 278 | 283 | PF00397 | 0.584 |
DOC_WW_Pin1_4 | 398 | 403 | PF00397 | 0.704 |
LIG_14-3-3_CanoR_1 | 388 | 395 | PF00244 | 0.394 |
LIG_14-3-3_CanoR_1 | 63 | 68 | PF00244 | 0.559 |
LIG_14-3-3_CanoR_1 | 92 | 100 | PF00244 | 0.625 |
LIG_Actin_WH2_2 | 324 | 341 | PF00022 | 0.559 |
LIG_Actin_WH2_2 | 33 | 49 | PF00022 | 0.590 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.671 |
LIG_eIF4E_1 | 240 | 246 | PF01652 | 0.463 |
LIG_FHA_1 | 149 | 155 | PF00498 | 0.503 |
LIG_FHA_1 | 245 | 251 | PF00498 | 0.474 |
LIG_FHA_2 | 184 | 190 | PF00498 | 0.495 |
LIG_FHA_2 | 202 | 208 | PF00498 | 0.491 |
LIG_FHA_2 | 271 | 277 | PF00498 | 0.625 |
LIG_FHA_2 | 342 | 348 | PF00498 | 0.476 |
LIG_LIR_Apic_2 | 139 | 144 | PF02991 | 0.493 |
LIG_LIR_Gen_1 | 178 | 185 | PF02991 | 0.483 |
LIG_LIR_Nem_3 | 178 | 183 | PF02991 | 0.472 |
LIG_MYND_1 | 57 | 61 | PF01753 | 0.527 |
LIG_Pex14_2 | 180 | 184 | PF04695 | 0.451 |
LIG_Pex14_2 | 78 | 82 | PF04695 | 0.456 |
LIG_Rb_LxCxE_1 | 119 | 133 | PF01857 | 0.520 |
LIG_REV1ctd_RIR_1 | 181 | 191 | PF16727 | 0.465 |
LIG_SH2_CRK | 195 | 199 | PF00017 | 0.282 |
LIG_SH2_NCK_1 | 124 | 128 | PF00017 | 0.501 |
LIG_SH2_NCK_1 | 67 | 71 | PF00017 | 0.560 |
LIG_SH2_PTP2 | 141 | 144 | PF00017 | 0.515 |
LIG_SH2_SRC | 124 | 127 | PF00017 | 0.504 |
LIG_SH2_STAP1 | 367 | 371 | PF00017 | 0.527 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.584 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.549 |
LIG_SH2_STAT5 | 44 | 47 | PF00017 | 0.523 |
LIG_SH3_3 | 139 | 145 | PF00018 | 0.547 |
LIG_SH3_3 | 243 | 249 | PF00018 | 0.435 |
LIG_SH3_3 | 396 | 402 | PF00018 | 0.687 |
LIG_SUMO_SIM_par_1 | 247 | 253 | PF11976 | 0.522 |
LIG_TRAF2_1 | 108 | 111 | PF00917 | 0.520 |
LIG_TRAF2_1 | 144 | 147 | PF00917 | 0.549 |
LIG_TRAF2_1 | 344 | 347 | PF00917 | 0.485 |
MOD_CK1_1 | 255 | 261 | PF00069 | 0.560 |
MOD_CK1_1 | 341 | 347 | PF00069 | 0.327 |
MOD_CK1_1 | 401 | 407 | PF00069 | 0.782 |
MOD_CK2_1 | 183 | 189 | PF00069 | 0.497 |
MOD_CK2_1 | 201 | 207 | PF00069 | 0.445 |
MOD_CK2_1 | 270 | 276 | PF00069 | 0.599 |
MOD_CK2_1 | 341 | 347 | PF00069 | 0.414 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.678 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.470 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.613 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.525 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.634 |
MOD_GSK3_1 | 401 | 408 | PF00069 | 0.753 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.594 |
MOD_N-GLC_1 | 46 | 51 | PF02516 | 0.590 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.441 |
MOD_NEK2_1 | 183 | 188 | PF00069 | 0.395 |
MOD_NEK2_1 | 338 | 343 | PF00069 | 0.563 |
MOD_NEK2_1 | 46 | 51 | PF00069 | 0.512 |
MOD_NEK2_2 | 233 | 238 | PF00069 | 0.431 |
MOD_PIKK_1 | 136 | 142 | PF00454 | 0.535 |
MOD_PIKK_1 | 168 | 174 | PF00454 | 0.563 |
MOD_PIKK_1 | 250 | 256 | PF00454 | 0.534 |
MOD_PIKK_1 | 387 | 393 | PF00454 | 0.489 |
MOD_PIKK_1 | 91 | 97 | PF00454 | 0.617 |
MOD_PKA_2 | 221 | 227 | PF00069 | 0.466 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.625 |
MOD_PKA_2 | 338 | 344 | PF00069 | 0.566 |
MOD_PKA_2 | 387 | 393 | PF00069 | 0.609 |
MOD_PKA_2 | 91 | 97 | PF00069 | 0.594 |
MOD_Plk_1 | 168 | 174 | PF00069 | 0.452 |
MOD_Plk_1 | 367 | 373 | PF00069 | 0.510 |
MOD_Plk_1 | 42 | 48 | PF00069 | 0.527 |
MOD_Plk_2-3 | 164 | 170 | PF00069 | 0.504 |
MOD_Plk_2-3 | 196 | 202 | PF00069 | 0.333 |
MOD_Plk_4 | 116 | 122 | PF00069 | 0.576 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.496 |
MOD_Plk_4 | 367 | 373 | PF00069 | 0.532 |
MOD_ProDKin_1 | 278 | 284 | PF00069 | 0.589 |
MOD_ProDKin_1 | 398 | 404 | PF00069 | 0.707 |
MOD_SUMO_rev_2 | 101 | 108 | PF00179 | 0.574 |
MOD_SUMO_rev_2 | 81 | 88 | PF00179 | 0.540 |
TRG_DiLeu_BaEn_1 | 150 | 155 | PF01217 | 0.268 |
TRG_DiLeu_BaEn_1 | 299 | 304 | PF01217 | 0.675 |
TRG_ENDOCYTIC_2 | 124 | 127 | PF00928 | 0.400 |
TRG_ENDOCYTIC_2 | 195 | 198 | PF00928 | 0.542 |
TRG_ENDOCYTIC_2 | 240 | 243 | PF00928 | 0.413 |
TRG_ER_diArg_1 | 331 | 334 | PF00400 | 0.493 |
TRG_NES_CRM1_1 | 147 | 161 | PF08389 | 0.509 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IK09 | Leptomonas seymouri | 59% | 93% |
A0A0S4KNI9 | Bodo saltans | 21% | 100% |
A0A1X0P8J5 | Trypanosomatidae | 32% | 100% |
A0A3S7X7H5 | Leishmania donovani | 91% | 100% |
A4HAF5 | Leishmania braziliensis | 73% | 100% |
A4I9L1 | Leishmania infantum | 91% | 100% |
Q4Q3G7 | Leishmania major | 90% | 100% |